Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Vasu Tumati"'
Autor:
Lan Yu, Vasu Tumati, Shu-Fen Tseng, Feng-Ming Hsu, D. Nathan Kim, David Hong, Jer-Tsong Hsieh, Corbin Jacobs, Payal Kapur, Debabrata Saha
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 14, Iss 12, Pp 1203-1212 (2012)
Radiation therapy (RT) is an effective strategy for the treatment of localized prostate cancer (PCa) as well as local invasion. However, some locally advanced cancers develop radiation resistance and recur after therapy; therefore, the development of
Externí odkaz:
https://doaj.org/article/5b52786cf26441eea5365add601bbf75
Autor:
Michelle Myers, Vasu Tumati, Tara Spivey, Thomas Tigges, Christopher A. Leagre, Jessica Durk, Trisha Engle, Julie Schneiders, Nick Beaudrie, Rina Yadav, Erica Giblin, Kristen Govert, Patrick Henman, Tessa Bair, Niraj K. Gupta, Marjaorie Hancock, Thomas Dugan, Robert H. Liebross
Publikováno v:
Cancer Research. 81:PS13-39
Background:Administration of neoadjuvant Pertuzumab (P), trastuzumab (T) along with chemotherapy is the standard of care for the management of locally advanced/inflammatory Her-2 positive breast cancer. Neutropenia and diarrhea are often the signific
Autor:
Felix Y. Feng, Vasu Tumati, Steven G. Allen, Krithika Suresh, William C. Jackson, Samuel D. Kaffenberger, Shruti Jolly, Simpa S. Salami, Daniel E. Spratt, Arvin K. George, Brent K. Hollenbeck, Robert T. Dess, Matthew J. Schipper, Rohit Mehra, David C. Miller, Jason W.D. Hearn, Neil Desai, Ganesh S. Palapattu, Todd M. Morgan
Publikováno v:
European Urology. 74:413-419
Background Intermediate clinical endpoints (ICEs) prognostic for overall survival (OS) are needed for men receiving postprostatectomy radiation therapy (PORT) to improve clinical trial design. Objective To identify a potential ICE for men receiving P
Autor:
Simpa S. Salami, Jason W.D. Hearn, Vasu Tumati, Samuel D. Kaffenberger, Daniel E. Spratt, Zachary S. Zumsteg, Raquibul Hannan, Rohit Mehra, Arvin K. George, Shuang G. Zhao, Payal D. Soni, Todd M. Morgan, Brent K. Hollenbeck, Robert T. Dess, Matthew J. Schipper, Felix Y. Feng, Neil Desai, William C. Jackson, Krithika Suresh
Publikováno v:
European Urology Oncology. 1:276-282
Disease progression following salvage radiotherapy (SRT) for prostate cancer (PC) is common, and the time to biochemical recurrence (BCR) is heterogeneous.To describe the temporal distribution and clinical impact of BCR following SRT and model outcom
Autor:
Syed Rizvi, Pier Paolo Scaglioni, Hsiao Ching Li, Jason W Wachsmann, Robert H. Collins, Navid Sadeghi, Weina Chen, Madhuri Vusirikala, Prapti A. Patel, Neil Desai, Vasu Tumati, Lakshya U. Trivedi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 100:1126-1132
Purpose Lymphomas with MYC and either BLC2 or BCL6 rearrangements or MYC and BCL-2 protein overexpression, classified as double-hit (DHL) or double-expressor (DEL) lymphomas, respectively, are associated with poorer response to standard immunochemoth
Autor:
John M. Truelson, Xian Jin Xie, Larry L. Myers, Randall S. Hughes, I. Smith, Pierre Lavertu, Baran D. Sumer, Stuart J. Wong, D. Wang, Min Yao, Vasu Tumati, Lucien A. Nedzi, Musaddiq J. Awan
Publikováno v:
Annals of Oncology. 29:998-1003
Background The optimal regimen of chemotherapy and reirradiation (re-XRT) for recurrent head and neck squamous cell carcinoma (HNSCC) is controversial. We report the final outcomes of a multicenter phase II trial evaluating cetuximab and cisplatin-ba
Autor:
Robert Timmerman, David Miller, Debra L. Richardson, Jayanthi S. Lea, Kevin Albuquerque, Vasu Tumati, Chul Ahn
Publikováno v:
International journal of radiation oncology, biology, physics. 106(3)
Purpose Our purpose was to assess the feasibility, safety, and efficacy of stereotactic ablative radiation therapy (SAbR) as an alternative for intracavitary/interstitial brachytherapy boost for locally advanced cervical cancer (LACC) after initial c
Autor:
Baran D. Sumer, Larry L. Myers, Saad A. Khan, David J. Sher, Lucien A. Nedzi, John M. Truelson, Randall S. Hughes, Lawrence Hoang, Vasu Tumati
Publikováno v:
Head & Neck.
BACKGROUND This study sought to determine the oncologic impact of delays to surgery, radiotherapy, and completion of therapy in patients with head and neck squamous cell carcinoma. METHODS The impact of biopsy to surgery (BTS) time, surgery to start
Autor:
D. W Nathan Kim, Akash Nanda, L. Chinsoo Cho, David Raben, Xian Jin Xie, David A. Pistenmaa, Jeffrey Brindle, Raquibul Hannan, Yair Lotan, Brian D. Kavanagh, Robert Timmerman, Vasu Tumati, Susan Cooley
Publikováno v:
European Journal of Cancer. 59:142-151
Background We report the outcome of a phase I/II clinical trial of stereotactic body radiation therapy (SBRT) for low (LR) and select intermediate risk (IR) prostate cancer (PCa) patients. Patients and methods Eligible patients included men with pros
Autor:
Debra L. Richardson, Elsa Wise, Sandra Lawson, Jayanthi S. Lea, Siobhan M. Kehoe, Kevin Albuquerque, Ramzi Abdulrahman, Sheila Wolcott, Vasu Tumati, Michael R. Folkert, Matthew Carlson
Publikováno v:
Brachytherapy. 15:341-346
Purpose Interstitial brachytherapy is an essential component of definitive treatment for locally advanced gynecological malignancies. Although many outpatient centers are capable of delivering the radiation component of brachytherapy, they are not as